Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study
Oct 04, 2019 - The FDA approves the label update of Puma Biotech's (PBYI) breast cancer drug Nerlynx in order to add data from the CONTROL study. Stock gains.
Oct 04, 2019 - J&J (JNJ) settles with two Ohio plaintiffs for $10 million. FDA updates for AstraZeneca (AZN), Merck (MRK) and others and ESMO presentations by big pharma companies in focus.
Oct 03, 2019 - Novartis (NVS) announces additional positive data from the phase III PREVENT study on spondylitis drug, Cosentyx.
Oct 02, 2019 - Novartis (NVS) announces data from late-stage studies on asthma drugs and breast cancer drug, Kisqali.
Oct 01, 2019 - The following slide deck was published by Novartis AG in conjunction with this event.
Sep 30, 2019 - Roche (RHHBY) gets FDA approval for Rituxan to treat children with two rare blood vessel disorders. The company also extends the offer period to acquire Spark Therapeutics.
Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
Sep 26, 2019 - Sanofi's (SNY) stock is on an upward trajectory this year. Let us have a look at the reasons for the same.
Sep 26, 2019 - Achillion's (ACHN) oral factor D inhibitor, danicopan, receives Breakthrough Therapy designation from the FDA as a treatment option for PNH. Shares up.